Triple negative (TN) BC accounts for 15–20% of BCs and it is characterized by the absence of ER, PgR and HER2 overexpression; it usually presents with a very aggressive phenotype, frequently exhibiting high Ki-67 index and high histological grade. This evidence concerns the gene ERBB2 and breast cancer.